Yahoo News reports:
U.S. health regulators are looking at authorizing a potential fourth dose of a COVID-19 vaccine in the fall, the Wall Street Journal reported on Sunday citing sources familiar with the matter.
The Food and Drug Administration has been reviewing data to authorize a second booster dose of the messenger RNA vaccines from Pfizer Inc and partner BioNTech SE and vaccines from Moderna Inc, the report added. The FDA did not immediately respond to a request for comment.
The agency last month cut the interval to get a booster dose of COVID-19 vaccines from Pfizer and BioNTech as well as from Moderna, in a bid to provide better protection sooner against the Omicron variant.
Read the full article. The WSJ report is behind a paywall.
U.S. FDA considers approving a second COVID-19 booster shot -WSJ https://t.co/N7OyQroNO0 pic.twitter.com/aFW4E1jDjL
— Reuters (@Reuters) February 20, 2022